2012-04-27

[DIV28SUPER] Apply to join the APA Science Student Council

Please see message below and contact Nicole Singer (nsinger@apa.org) with any questions or to apply.

---


Dear listserv,

 

We would like to make sure you are aware of the great opportunity described below for a few psychology graduate students to get involved in APA and get great leadership experience!  The deadline for students to apply was this week, however we will now continue to accept applications until Wednesday, May 2, (next week) at the latest. 

 

The positions open are in the following four areas so students applying must do research that falls in one of these broad categories.  They must also have completed at least one year of graduate school and have at least two years of graduate school remaining before earning a PhD.

 

·        Behavioral Neuroscience

·        Health Psychology

·        Social/Personality

·        Clinical Science

 

Please feel free to contact me if you have any questions!  Any interested students should also feel free to contact me directly.

 

Thanks,

-Nicolle

 

Nicolle Singer | Science Programs Associate

Outreach & Development, Science Directorate
American Psychological Association
750 First Street NE, Washington, DC 20002-4242
Tel: 202-336-5954 |  Fax: 202-336-5953

email: nsinger@apa.org | www.apa.org

   

 

 

Graduate Students: Apply to join the APA Science Student Council

 

The Science Directorate is currently accepting applications to the APA Science Student Council (SSC). Formed in 1993, the SSC is a diverse group of research-oriented psychology graduate students who serve as an advisory group to the APA Science Directorate. The Council represents the interests of research-oriented students by providing valuable advice to the Directorate on how it can best serve the science student population. The Council has been actively involved in a number of projects, including awarding prizes for graduate-level research, organizing student programs for the APA Convention, writing newsletter articles about graduate student issues, learning about and participating in advocacy for psychological funding, and making recommendations on the Directorate's student programs. The Council reports to and collaborates with the Board of Scientific Affairs and works cooperatively with the American Psychological Association of Graduate Students.

 

The Directorate is seeking applications from graduate students to serve two-year terms beginning September 1, 2012, during which time they will be actively engaged SSC members. By the beginning of the SSC term, new members must have completed at least one year of graduate school, and have at least two years of graduate school remaining before receiving their PhD. SSC members are required to attend two weekend meetings per year in Washington, DC, at APA's expense, with the potential to attend additional optional APA governance events. In addition, SSC members are expected to remain available via e-mail during an unofficial third (non-meeting) year to advise new members (this third year can be post-doctoral).

 

Four (4) positions will be available on the Council for the September 2012-September 2014 term. One person in each of the following areas of research will be selected:

 

·        Behavioral Neuroscience

·        Clinical Science

·        Health Psychology

·        Social/Personality

 

Potential SSC applicants are encouraged to contact current SSC members in their area of interest to discuss the positions and responsibilities. The current members contact info is available on the website.

 

Please note that the Council strives for diversity in all appropriate ways, including geographic diversity. Consequently, no more than one student from any given department may occupy a seat on the SSC at any given time. Please check the list of current members before applying. If you have a question about your eligibility, please contact the Science Directorate.

 

To apply to the SSC, please provide the following:

1.      A letter of recommendation (not to exceed 500 words) emailed from the student's advisor, endorsing the nomination.

2.      An essay written by the student about how s/he could contribute as a Council member, any previous related skills and experience, and why s/he would fit as a good addition to SSC (not to exceed 500 words).

3.      A description written by the student about his/her research in psychology that demonstrates commitment to psychological science (not to exceed 300 words).

4.      Abbreviated curriculum vitae (not to exceed two pages).

 

Applications are due electronically by April 26, 2012. Please submit all application materials via email. New members will be selected in the summer for terms that begin September 1, 2012. 

 

Application materials may be submitted as Word documents, zip files or as PDFs. Please note that our e-mail system blocks files that are 10MB or larger. If you try to e-mail materials that are larger than this limit, we will not receive your e-mail.

If the sum of your files is larger than 10MB, we suggest sending each attachment in a separate e-mail.

 

After we receive your application materials, we will send a confirmation e-mail. If you do not receive a confirmation e-mail within two business days of sending your materials, it means that we did not receive your application (see note, above, regarding file size). Please contact us before resubmitting your materials.

 

Please direct questions to the APA Science Directorate by telephone (202) 336-6000 or by email.

 

Learn more about the SSC and the Council's current projects.

 

 

 

 




--
Kelly Dunn, Ph.D.
NIDA Postdoctoral Fellow
Johns Hopkins University School of Medicine
5510 Nathan Shock Drive
Baltimore, MD 21224
BPRU Phone: (410) 550-2254
CLH Phone: (410) 550-5370
Fax: (410) 550-0030
 
WARNING:  E-mail sent over the Internet is not secure.  Information sent by e-mail may not remain confidential.
DISCLAIMER:  This e-mail is intended only for the individual to whom it is addressed.  It may be used only in accordance with applicable laws.  If you received this e-mail by mistake, notify the sender and destroy the e-mail

_____________________________ div28SUPER@lists.apa.org
Div28m members may post here list archive
twitter: @apadiv28 join our network

2012-04-26

[DIV28SUPER] Cardinal Health Foundation Invites Local Nonprofit Organizations to Apply for Grants to Prevent Prescription Drug Abuse

Please see a potential funding opportunity below:
-----

Cardinal Health Foundation Invites Local Nonprofit Organizations to Apply for Grants to Prevent Prescription Drug Abuse

For the third consecutive year, the Cardinal Health Foundation is inviting nonprofit organizations in seven U.S. cities and Puerto Rico to apply for grant funding to support local efforts to prevent the abuse and misuse of prescription medications.

In an effort to address the prescription drug abuse epidemic in America, the foundation encourages grassroots efforts to raise awareness and promote education and prevention of this public health issue. The grant program will provide funding to nonprofit organizations to target prescription drug misuse and abuse in their communities.

Specifically, the program is intended to reduce the misuse or abuse of prescription medications by youth, adults, and the elderly. To help achieve this goal, Cardinal Health is funding programs designed to increase awareness of the prescription drug abuse issue; knowledge of how to reduce access to prescription drugs and how to properly dispose of them; and awareness of the consequences of misusing or abusing prescription medications.

Nonprofit 501(c)(3) organizations in the following cities/areas are invited to apply: Albuquerque, New Mexico;; Central Ohio; El Paso, Texas; LaVergne, Tennessee; Little Rock, Arkansas; Northern Chicago (Lake, McHenry and Kenosha counties); Radcliff, Kentucky; and Puerto Rico.

Applicants are strongly encouraged to incorporate into their proposals the use of the comprehensive suite of GenerationRx prescription drug abuse awareness materials created to provide healthcare providers, pharmacists, parents, teachers, youth group leaders, and other concerned citizens with resources to educate teens, adults, and the elderly about the realities and dangers of prescription drug abuse and misuse.

The foundation will provide up to $200,000 in grants of $5,000 to $15,000.

Complete grant program guidelines and the online application are available at the Cardinal Health Web site.




--
Kelly Dunn, Ph.D.
NIDA Postdoctoral Fellow
Johns Hopkins University School of Medicine
5510 Nathan Shock Drive
Baltimore, MD 21224
BPRU Phone: (410) 550-2254
CLH Phone: (410) 550-5370
Fax: (410) 550-0030
 
WARNING:  E-mail sent over the Internet is not secure.  Information sent by e-mail may not remain confidential.
DISCLAIMER:  This e-mail is intended only for the individual to whom it is addressed.  It may be used only in accordance with applicable laws.  If you received this e-mail by mistake, notify the sender and destroy the e-mail

_____________________________ div28SUPER@lists.apa.org
Div28m members may post here list archive
twitter: @apadiv28 join our network

2012-04-24

[DIV28SUPER] NIDA Neuroscience Update April 24, 2012

 

Table of Contents

I.  RFA-HG-12-009 Clinical Sequencing Exploratory Research (U01) 

II. NOT-DA-12-013  National Institute on Drug Abuse (NIDA) Seeks Applications Using the JAX Diversity Outcross (DO) Mice

III. Multidisciplinary Studies of HIV/AIDS and Aging )(R21, R01, R03)

PAR-12-174 (http://grants.nih.gov/grants/guide/pa-files/PAR-12-174.html) R21

PAR-12-175 (http://grants.nih.gov/grants/guide/pa-files/PAR-12-175.html) R01

PAR-12-176 (http://grants.nih.gov/grants/guide/pa-files/PAR-12-176.html) R03

IV. Model Organisms to Human Biology – Cancer Genetics Conference

 

I. RFA-HG-12-009 Clinical Sequencing Exploratory Research (U01) 

The NHGRI and NIDA seek grant applications to explore, within an active clinical setting, the application of genomic sequence data to the care of patients.  Our understanding of human genetic variation and its association with disease risk and with individual response to treatment continues to expand rapidly.  Simultaneously, a revolution has occurred in genomic sequencing technologies, making it technically and economically feasible to consider the application and utilization of genomic sequence data in clinical care.  Applications submitted in response to this FOA will address critical questions about the application of genomic sequencing to clinical care of individual patients, from generation of genomic sequence data, to interpretation and translation of the data for the physician, to communication to the patient, including an examination of the ethical, legal and psychosocial implications of bringing broad genomic data into the clinic.

Letter of Intent due June 26th, 2012

Applications are due:  July 26, 2012, by 5:00 PM local time of applicant organization.

If interested, please contact: 

Joni L. Rutter, PhD

Acting Director

Division of Basic Neuroscience and Behavioral Research

National Institute on Drug Abuse/NIH/DHHS

301.435.0298

II. NOT-DA-12-013  National Institute on Drug Abuse (NIDA) Seeks Applications Using the JAX Diversity Outcross (DO) Mice

The Genetics and Molecular Neurobiology Research Branch (GMNRB) at the National Institute on Drug Abuse (NIDA) seeks applications using the JAX Diversity Outcross (DO) mice to identify genetic variants associated with substance abuse and addiction as well as treatment response.  To apply for grants within this area of interest, refer to PA-11-026 Molecular Genetics of Drug Addiction and Related Co-Morbidities (R01)  (http://grants.nih.gov/grants/guide/pa-files/PA-11-026.html).

The diversity outcross mice permit fine mapping of genetic loci for complex trait with far less effort and greater resolution than before with other mouse resources.   Papers highlighting this resource can be found in the Feb 16, 2012 issues of Genetics www.genetics.org and G3: Genes|Genomes|Genetics www.g3journal.org

Identification the gene variants underlying the following traits DO mice that are of interest to GMNRB include but are not limited to:

·         Motivation to work for a drug as measured by drug self-administration breakpoint.

·         Persistence of drug seeking behavior

·         Compulsivity of drug seeking behavior

·         Preference between drug and sucrose following drug self-administration and the absence of any withdrawal symptoms

·         Withdrawal

·         Tolerance

·         Sensitization

·         Novelty seeking

·         Different measures of impulsivity, e.g.  5CSRTT (five-choice serial reaction time task) and reversal learning

·         Goal trackers vs. sign Trackers, i.e. difference in cue reactivity and auto-shaping.

·         Measures of anxiety associated with drug seeking behavior.

·         Altered brain circuitry following drug exposure

·         Drug Toxicity

·         Pharmacokinetics

·         Phenotypes produced by GXE interactions that may affect substance abuse and addiction phenoytpes such as maternal separation, victimization by aggression,  learned helplessness in utero exposure to drugs of abuse and environmental toxins such as lead,  and vulnerability to drugs of abuse during puberty and early adulthood.

·         Genetic modifiers of knockout mouse phenotypes affecting drug response.

·         Treatment response to pharmacological agents that have potential for treating substance abuse

·         Nicotine, cocaine, and heroin vaccine responses such antibody titer and amount of free and bound drug in tissues.

The JAX:DO are available from The Jackson Laboratory (Bar Harbor, ME), as JAXMice stock number 009376. Sibling information at each generation is tracked and made available upon request.  http://cgd.jax.org/datasets/phenotype/SvensonDO.shtml.

Inquiries


Please direct all inquiries to:

Jonathan D. Pollock, Ph.D.
Chief
Genetics and Molecular Neurobiology Research Branch
Division of Basic Neuroscience and Behavioral Research
National Institute on Drug Abuse
6001 Executive Blvd. Rm 4103
Bethesda, MD 20892
(For Fedex Delivery the address is Rockville, MD 20852)
Telephone: 301-435-1309
FAX:  301-594-6043
Email.
jpollock@mail.nih.gov

 

 

III. Multidisciplinary Studies of HIV/AIDS and Aging )(R21, R01, R03)

PAR-12-174 (http://grants.nih.gov/grants/guide/pa-files/PAR-12-174.html) R21

PAR-12-175 (http://grants.nih.gov/grants/guide/pa-files/PAR-12-175.html) R01

PAR-12-176 (http://grants.nih.gov/grants/guide/pa-files/PAR-12-176.html) R03

This FOA invites applications proposing to study HIV infection, HIV-associated conditions, HIV treatment, and/or biobehavioral or social factors associated with HIV/AIDS in the context of aging and/or in older adults. Research approaches of interest include clinical translational, observational, and intervention studies in domestic and international settings.

 

 

IV. Model Organisms to Human Biology – Cancer Genetics Conference

The Genetics Society of America invites you to attend the Model Organisms to Human Biology – Cancer Genetics Conference, co-sponsored by NCI and in Washington, D.C., June 17-21, 2012 at the Omni Shoreham Hotel.  This interactive meeting will bring together investigators who study cancer-relevant problems in model organisms with those who study human cancer.  Keynote speakers include Bert Vogelstein, Eric Lander and Angelika Amon.  Eric Green, Director, NHGRI, will chair a mini-symposium on modENCODE at MOHB. This GSA Conference dovetails with the NIH-sponsored symposium on June 20 -21, which marks the completion of the ModENCODE project. Chris Kaiser, Director-Designate, NIGMS, will also make a presentation. For the complete agenda, invited speakers and to register for the MOHB-Cancer Genetics Conference, please see www.mohb.org/2012/.  Deadline for early (discounted) registration:  May 10, 2012. 

 

----

The National Institute on Drug Abuse at the National Institutes of Health is an agency of the United States Department of Health and Human Services  TO UNSUBSCRIBE: send email to listserv@list.nih.gov<mailto:listserv@list.nih.gov>, Copy and paste UNSUBSCRIBE NIDA_NEURO_SCIENCE-L   in the message body of the email
- You will receive a confirmation email if successful. If you have problems contact
jpollock@mail.nih.gov 
   301-435-1309

2012-04-23

[DIV28SUPER] 2012 Office of National Drug Control Policy- National Drug Control Strategy

Hello,

Here is a link to the Office of National Drug Control Policy's updated National Drug Control Strategy that emphasizes drug abuse prevention and treatment, with a particular focus on the criminal justice system and the role of drug abuse treatment in the Affordable Care Act.

http://www.whitehouse.gov/blog/2012/04/17/drug-policy-21st-century-0

Warm regards
--
Kelly Dunn, Ph.D.
NIDA Postdoctoral Fellow
Johns Hopkins University School of Medicine
5510 Nathan Shock Drive
Baltimore, MD 21224
BPRU Phone: (410) 550-2254
CLH Phone: (410) 550-5370
Fax: (410) 550-0030
 
WARNING:  E-mail sent over the Internet is not secure.  Information sent by e-mail may not remain confidential.
DISCLAIMER:  This e-mail is intended only for the individual to whom it is addressed.  It may be used only in accordance with applicable laws.  If you received this e-mail by mistake, notify the sender and destroy the e-mail

_____________________________ div28SUPER@lists.apa.org
Div28m members may post here list archive
twitter: @apadiv28 join our network

2012-04-22

[DIV28SUPER] NYTimes: How Psychedelic Drugs Can Help Patients Face Death

For a small group of researchers and their patients facing death, psychedelic drugs aren't a hippie palliative. They're a new way to approach the most dire time of life. http://nyti.ms/JkfNTQ

___________________ div28SUPER@lists.apa.org _____________________
Div28m members may post here subscribers corner: http://lists.apa.org

2012-04-21

[DIV28SUPER] WSJ interview with M Kleiman

Current drug policies do more damage than they need to/much less good than they might, argues Prof. Mark Kleiman. Wsj http://t.co/7VI7oEy5

[DIV28SUPER] NYTimes: Post-Prozac Nation

Just because the wonder drugs of the '90s have disappointed doesn't mean the science should be completely discarded. But it does mean we need a more sophisticated theory of depression. http://nyti.ms/HK1jIQ

___________________ div28SUPER@lists.apa.org _____________________
Div28m members may post here subscribers corner: http://lists.apa.org

2012-04-18

[DIV28SUPER] RA positions available

Greetings all-

The Center for Addictions, Personality and Emotion Research (CAPER) has four
full time Faculty Research Assistant (RA) positions available for the next
contract year, July 1, 2012 – June 30, 2013. A description of each of the
four positions is attached to this email. Please note that any given
project could have some flexibility regarding start date as determined by
the faculty or supervisor in charge.

For best consideration, all applicants should email a cover letter and
CV/resume to Ronneal Mathews (ronnealmathews@yahoo.com) by Tuesday, May 1st.
In your cover letter, you may identify by preference, up to two of the four
positions for which you wish to be considered. The cover letter should
address your specific qualifications for the position(s) to which you are
applying.

The University of Maryland, College Park, actively subscribes to a policy of
equal employment opportunity, and will not discriminate against any employee
or applicant because of race, age, sex, color, sexual orientation, physical
or mental disability, religion, ancestry or national origin, marital status,
genetic information, or political affiliation. Minorities and women are
encouraged to apply.

If you have any questions, please contact me or stop by my office.

Regards,


Gaye Bugenhagen
Director of Administrative Services
Center for Addictions, Personality and Emotion Research
University of Maryland
2103 Cole Field House
College Park, MD 20742-4411
Office: 301.405.0899
Fax: 301.405.3223
Email: gbugenha@umd.edu

___________________ div28SUPER@lists.apa.org _____________________
Div28m members may post here subscribers corner: http://lists.apa.org

[DIV28SUPER] Presentations from FDA public meeting on naloxone for overdose fatality prevention

Hello all,

For those interested, here is a link to the presentations provided during the FDA public workshop regarding the role of naloxone for overdose fatality prevention- a topic relevant to many of our members.

http://www.fda.gov/Drugs/NewsEvents/ucm277119.htm

Kelly
--
Kelly Dunn, Ph.D.
NIDA Postdoctoral Fellow
Johns Hopkins University School of Medicine
5510 Nathan Shock Drive
Baltimore, MD 21224
BPRU Phone: (410) 550-2254
CLH Phone: (410) 550-5370
Fax: (410) 550-0030
 
WARNING:  E-mail sent over the Internet is not secure.  Information sent by e-mail may not remain confidential.
DISCLAIMER:  This e-mail is intended only for the individual to whom it is addressed.  It may be used only in accordance with applicable laws.  If you received this e-mail by mistake, notify the sender and destroy the e-mail

_____________________________ div28SUPER@lists.apa.org
Div28m members may post here list archive
twitter: @apadiv28 join our network

2012-04-10

[DIV28SUPER] University of Vermont Postdoc Position in Drug Abuse Research

University of Vermont announces availability of NIDA postdoctoral
research fellowship positions in an internationally recognized center
of excellence on drug abuse. The Human Behavioral Pharmacology
Laboratory, est. in 1986, is a research unit of the Department of
Psychiatry that studies biological, environmental and pharmacological
factors influencing abuse of licit and illicit drugs. Fellows train in
wide range of human-laboratory and treatment-outcome research.

*Openings with Drs. Sarah H. Heil on clinical trials of behavioral
interventions to increase contraceptive use among drug-dependent women
and lab studies of neonatal abstinence syndrome in opioid-exposed
infants and Stephen T. Higgins on behavioral treatments for cocaine
dependence and smoking-cessation in pregnant women.

*2-3 yr. Appointment

*Applicants must have completed doctoral training in psychology or a
related discipline and be U.S. citizens or permanent residents.
Trainees are selected on the basis of scholastic record and commitment
to drug-abuse research.

*Supported by an NIDA/NIH Institutional Training Award.

*Forward CV, statement of research interests, 3 letters of reference
to Dr. Higgins c/o: Diana Cain, University of Vermont, Dept. of
Psychiatry, 1 South Prospect St. UHC - MS#482, Burlington, VT 05401,
Email: Diana.Cain@uvm.edu

___________________ div28SUPER@lists.apa.org _____________________
Div28m members may post here subscribers corner: http://lists.apa.org

2012-04-06

[DIV28M] HOPE Program seeks volunteer trainers

The training and public service opportunity is sent to you courtesy of the Committee on Women in Psychology.  Please circulate as you see fit.

-Nancy
 
Nancy A. Piotrowski, Ph.D.
Core Faculty, General Psychology
Harold Abel School of Social and BehavioralSciences
Department of Psychology, Capella University
 
President, Napa Solano Psychological Association 
Federal Advocacy Coordinator, Division 50, American Psychological Association
Website Chair, San Francisco Psychological Association

 
3450 Geary Boulevard, Suite #107
San Francisco, CA  94118
Phone & FAX by request
 
Email:              napiotrowski@yahoo.com
Skype:             napiotrowski
 
 
 "Not all those who wander are lost..." -J.R.R. Tolkien, 1954.



----- Forwarded Message -----


Improve your practice and help your community:
Become a Volunteer HIV Trainer!
 
The American Psychological Association's (APA) HIV Office for Psychology Education (HOPE) Program seeks doctorial psychology students and doctoral-level psychologists to become volunteer HIV/AIDS mental health trainers. Candidates should have HIV-related research, clinical, and training experience.
 
HOPE trainers are leaders within their respective fields, and have significant experience working with HIV infected or affected individuals. HOPE trainers are psychologists, psychiatrists, and mental health clinicians who volunteer their time to provide their communities with the knowledge and skills necessary to better serve their clients.
 
This program is funded under a five-year contract (280-09-0290) with the Center for Mental Health Services (CMHS) of the Substance Abuse and Mental Health Services Administration (SAMHSA), and the SAMHSA Minority AIDS Initiative Targeted Capacity Expansion (MAI-TCE) 12 Cities Program.
 
Selected applicants must commit to attend a training-of-trainer workshop in Chicago, IL, on May 31 – June 3, 2012.
 
The training-of-trainers will prepare volunteer trainers to use the HOPE Program's state-of-the-science training materials to train mental health providers and paraprofessionals. In addition, newly recruited volunteer trainers will join current trainers in experiencing two recently launched training curricula: Short Term Evidence Based Interventions for People Living With or at High Risk for HIV; and HIV Integrated Care: Integrating Mental Health, Substance Abuse Screening, Brief Assessment, and Referral to Treatment into HIV Prevention.
APA Continuing Education credit and up to a $200.00 reimbursement of receipted travel expenses to volunteers who successfully complete the training-of-trainers.
 
Volunteer trainers must commit to training at least 30 mental health professionals within one year of their completion of the training-of-trainers. HOPE Program staff will assist volunteer trainers in fulfilling their commitment by offering training design, marketing, and promotion support.
 
BENEFITS FOR PSYCHOLOGIST TRAINERS       
 
§  Deeper understanding of HIV-related mental health issues and their impact on access to services, retention in care, adherence to treatment;
§  Improved training design and delivery skills;
§  State-of-the-science training resources;
§  Access to a national network of HIV/AIDS related mental health providers;
§  National recognition as an APA HOPE Program HIV/AIDS trainer;
§  Opportunities to be a leader in training mental health, health care, and social service professionals regarding the psychosocial needs of people at risk for, and living with HIV; and
§  Opportunities to collect fees for training events offered by you.
 
 
APPLICATION PROCESS
 
Complete the online application http://forms.apa.org/pi/hope/ which includes submission of your vita and a letter that outlines your HIV-related clinical, research, and training experiences.
 
Applications must be received by April 25, 2012.
 
Qualified applicants will be chosen to reflect the diversity of the AIDS epidemic in terms of gender, ethnicity, populations served, and geographic proximity to one of the 12 metropolitan regions with the highest prevalence of HIV in the United State.  Email notification of selection will be made on April 26, 2012.
 
More information http://www.apa.org/pi/aids/programs/hope/index.aspx  For questions, or to request a paper application, contact David DeVito, HOPE Program Training Director; telephone: 202-216-7603; email: ddevito@apa.org.
 
 
 
 
 
David P. DeVito, MPA
Training Director, HOPE Program 
American Psychological Association
Public Interest Directorate
750 First Street NE,  Washington, DC 20002-4242
Tel: (202) 216.7603  |   Fax: (202) 336.6198

email: ddevito@apa.org  | www.apa.org
 
P Please consider the environment before printing this email.

 
  


2012-04-04

[DIV28SUPER] Submit a late-breaking abstract for the 2012 APA Convention

Do you want to go to the 2012 APA Convention in Orlando, but you missed the deadline for submitting an abstract?

- Then submit an abstract for one of two Late-Breaking Poster Sessions

 

Poster Session: New and High Impact Reports in Psychology

Friday, August 3, 5:00-6:00 p.m.

 

Proposals related to "late-breaking" psychological reports of current social events occurring nationally and internationally, or new and important research that has been completed since the original convention submission deadline in December 2011. Late-breaking posters should not be an extension of posters or presentations that have already been accepted and scheduled for the convention. Submit your proposal to the most appropriate division.

 

Examples of relevant submissions include:

 

a) recently completed research studies that potentially have a high impact on the field of psychology (e.g., a small pilot study demonstrating the efficacy of a novel treatment approach; recently completed research that is of immediate importance to a broad range of psychologists);

b) findings or issues that because of their topic and importance are of high relevance to the media and to non-psychologists;

c) issues related to a contemporary event with psychological impact (e.g., the psychological response or impact to the earthquake and tsunami in Japan while the disaster was current).

 

Presidential Poster Session: Posters Related to the Presidential Themes

Saturday, August 4, 4:00-6:00 p.m.

 

Proposals related to one of the three presidential themes will be considered.

 

The three presidential themes for the 2012 Convention are:

 

1.Interdisciplinary Team Science

2.Inter-professional Practice

3.Obesity

 

The online link for submitting late-breaking posters, along with additional information about the poster sessions, is posted on the APA website at www.apa.org/convention from now until May 15, 2012.  Don’t delay!

 

 

2012-04-03

[DIV28SUPER] Postdoctoral opportunity with George Mason University

Postdoctoral Research Fellow


The George Mason University, Department of Criminology, Law and
Society invites applications for a Postdoctoral Research Fellow
position. Professors Faye Taxman and Danielle Rudes seek to
collaborate on research at the interface between health and
criminology. This NIDA-funded position supports work on a randomized
controlled trial that seeks to further understand techniques and
factors to enhance intrinsic motivation for the syndemics of
offending, substance abuse and HIV risk behaviors.


The study will examine the impact of a brief intervention on
motivation, as well as access to key services and HIV testing. The
purpose is to support continued longitudinal follow-up offenders; as
well as to design several randomized intervention studies to reduce
substance use, HIV risk, recidivism, and to enhance outcomes.


Postdoctoral duties include: working on the study protocol, creating
and maintaining databases, conducting sophisticated statistical
analyses, managing field staff, collaborating with lab members on
empirical articles, assisting in the design of new studies, and
assisting in the supervision of our outstanding Graduate Research
Assistants and field staff.


Successful candidates will have a Ph.D. in a social science or
criminology; outstanding quantitative skills including experience with
SPSS and SAS; and excellent writing and presentation skills.
Experience with randomized controlled data and the study of change
over time is highly desired. Experience working with offender
populations is also a plus.


This position will be located in Baltimore, Maryland for 75 percent of the time.





--
Kelly Dunn, Ph.D.
NIDA Postdoctoral Fellow
Johns Hopkins University School of Medicine
5510 Nathan Shock Drive
Baltimore, MD 21224
BPRU Phone: (410) 550-2254
CLH Phone: (410) 550-5370
Fax: (410) 550-0030
 
WARNING:  E-mail sent over the Internet is not secure.  Information sent by e-mail may not remain confidential.
DISCLAIMER:  This e-mail is intended only for the individual to whom it is addressed.  It may be used only in accordance with applicable laws.  If you received this e-mail by mistake, notify the sender and destroy the e-mail

_____________________________ div28SUPER@lists.apa.org
Div28m members may post here list archive
twitter: @apadiv28 join our network

[DIV28SUPER] National Prescription Drug Take-back Day on April 28th

Hello colleagues,

The Drug Enforcement Administration has scheduled another National Prescription Drug Take-back Day on April 28th from 10:00 - 2:00. Please see their website for more information and locations:

http://www.deadiversion.usdoj.gov/drug_disposal/takeback/index.html

Warm regards,
Kelly

--
Kelly Dunn, Ph.D.
NIDA Postdoctoral Fellow
Johns Hopkins University School of Medicine
5510 Nathan Shock Drive
Baltimore, MD 21224
BPRU Phone: (410) 550-2254
CLH Phone: (410) 550-5370
Fax: (410) 550-0030
 
WARNING:  E-mail sent over the Internet is not secure.  Information sent by e-mail may not remain confidential.
DISCLAIMER:  This e-mail is intended only for the individual to whom it is addressed.  It may be used only in accordance with applicable laws.  If you received this e-mail by mistake, notify the sender and destroy the e-mail

_____________________________ div28SUPER@lists.apa.org
Div28m members may post here list archive
twitter: @apadiv28 join our network

[DIV28SUPER] AMERSA National Conference

 
Save the Date!

The 36th AMERSA Annual National Conference will be held November 1-3, 2012, at the Doubletree Hotel in Bethesda, MD


The Association for Medical Education and Research in Substance Abuse (AMERSA) is pleased to announce its 36th Annual AMERSA National Conference to be held on November 1-3, 2012, at the Doubletree Hotel in Bethesda, MD. The meeting will reflect on AMERSA's interdisciplinary strengths and the commitment to disseminate the latest developments in substance abuse education, prevention, treatment and research that challenge all health care professionals.We have planned an exciting program featuring research abstracts, skill-focused workshops, and plenary speakers addressing issues of national and international importance. Both CME and CEU credits will be offered.


The Call for Abstracts and Workshops is now open! Submit abstracts and workshops on-line at www.amersa.org (Deadline:May 25, 2012)


Conference Travel Awards –NEW for 2012

Applications are now being accepted for first-time attendees as well as second-time attendees!


AMERSA has opportunities for health professionals to learn about alcohol, tobacco and other drug issues. AMERSA has applied* for NIDA funding to underwrite a limited number or travel/lodging for health professionals to participate in our annual conference. You do not need to be an AMERSA member to apply.


(*Based on approved funding.) Deadline for submission is May 4, 2012.  For more information, and to apply on-line, please visit www.amersa.org


Confirmed Plenary Sessions include:

·A Spicy Debate: Ethan Nadelmann, JD, PhD and Kevin Sabet, PhD- Medical Marijuana

·Plenary Presentation:Alain Litwin MD, MPH and Irene Soloway, PA-C - Engaging Drug Users in Care and Treatment of Chronic Hepatitis

·Plenary Panel Session:Faye Taxman, PhD, June Tangney, PhD, and Peter Friedmann, MD, MPH - Substance Use and the Criminal Justice-Involved: From Community to Incarceration to Community

·Plenary Presentation:Traci Green, MSc, PhD - Community Approaches to the Opioid Overdose Epidemic

·Policy Luncheon on Addiction: Treatment Access and Workforce Capacity in the Setting of Health Reform


For further information, visit www.amersa.org or contact Doreen@amersa.org







--
Kelly Dunn, Ph.D.
NIDA Postdoctoral Fellow
Johns Hopkins University School of Medicine
5510 Nathan Shock Drive
Baltimore, MD 21224
BPRU Phone: (410) 550-2254
CLH Phone: (410) 550-5370
Fax: (410) 550-0030
 
WARNING:  E-mail sent over the Internet is not secure.  Information sent by e-mail may not remain confidential.
DISCLAIMER:  This e-mail is intended only for the individual to whom it is addressed.  It may be used only in accordance with applicable laws.  If you received this e-mail by mistake, notify the sender and destroy the e-mail

_____________________________ div28SUPER@lists.apa.org
Div28m members may post here list archive
twitter: @apadiv28 join our network

2012-04-01

[DIV28SUPER] NIDA Neuroscience Update, April 2, 2012

Table of Contents

 

I.                   (NOT-DA-12-012)  Notice of NIDA's Priorities for Human Genetics Research

II.                 Big Data is a Big Deal for New Multi-Agency Initiative

------

I. (NOT-DA-12-012)  Notice of NIDA's Priorities for Human Genetics Research

Purpose

This Notice communicates the NIDA's evolving human genetics funding priorities to help the addiction genetics community maximally align their research with NIDA's current strategic vision.

 

Multiple genes with relatively small effects, along with environmental and developmental factors, are likely to influence vulnerability to addiction.  The design and genetic approach chosen for studying addiction phenotypes will determine the types of genetic variants that can be identified, the genetic associations that each one yields, and its relevance to the addiction phenotype.  NIDA remains committed to a research program on the human genetics of substance abuse, and will continue to support human genetics research from discovery to application.

 

However, given the current budgetary climate and the increasing need to prioritize areas of research support, NIDA is taking the following steps:

 

1)      Give higher programmatic priority for funding to those applications that:

 

·         Identify and/or characterize the mechanistic roles and/or clinical application of genetic variants that have previously been demonstrated to contribute to addiction  

 

·         Propose targeted, whole-genome or -exome sequencing approaches. Note that applications proposing genome wide association studies (GWAS) may be given lower priority, and the applicant should indicate the rationale for why another approach was not chosen.  For candidate gene approaches, the allele(s) under study should include supporting evidence, e.g. a direct functional effect on the biological pathway(s), or strong prior evidence that it is associated with the drug abuse phenotype

 

·         Use bioinformatics and computational approaches that will leverage and integrate existing datasets, such as data from dbGaP, 1000 Genomes, epigenomics, ENCODE, imaging resources, etc., to maximize information on a targeted genetic regions, or be used to develop novel phenotypes or biomarkers 

 

·         Discuss and/or include a replication approach

 

2) Ensure portfolio balance through a coordinated programmatic assessment of the design and genetic approach chosen for human genetics applications by the NIDA Genetics Coordinating Committee

 

3) Accept only a limited number of applications requesting direct costs of $500,000 or more per year in any project year.

 

Taking these factors into consideration, prospective applicants are strongly encouraged to discuss their planned applications with NIDA's program staff during the early stages of application development to ensure that their application addresses these priorities.

 

For additional guidance on the types of information to include in human genetics of addiction applications, please see: http://ww2.drugabuse.gov/about/organization/Genetics/humanapp/index.html and for guidance on phenotypic assessments http://ww2.drugabuse.gov/about/organization/Genetics/ngcdomains

Please direct all inquiries to:
Joni Rutter, PhD
Acting Director, Division of Basic Neuroscience and Behavioral Research       
NIDA
6001 Executive Blvd
301.435.0298 (phone)
301.594.6043 (fax)
jrutter@mail.nih.gov
http://www.drugabuse.gov/
http://ww2.drugabuse.gov/about/organization/Genetics/index.html

-----------------

 

II. Big Data is a Big Deal for New Multi-Agency Initiative

The National Institute on Drug Abuse is pleased to join  with six other Federal Agencies in the Big Data Research and Development Initiative announced March 29 by the White House Office of Science and Technology Policy (OSTP).  (http://www.whitehouse.gov/blog/2012/03/29/big-data-big-deal)

Specifically, NIDA is participating  in a new joint solicitation supported by the National Science Foundation, five other NIH Institutes and the National Library of Medicine to advance the core scientific and technological means of managing, analyzing, visualizing, and extracting useful information from large and diverse data sets.  The phrase "big data" in this solicitation refers to large, diverse, complex, longitudinal, and/or distributed data sets generated from instruments, sensors, Internet transactions, email, video, click streams, and/or all other digital sources available today and in the future.  More information about NIH Research goals can be found in the solicitation entitled Core Techniques and Technologies for Advancing Big Data Science & Engineering (BIGDATA)  Because of the varied interests of the participating NIH components, prospective applicants are strongly encouraged to contact the scientific officers of any targeted NIH component prior to application. (Page 15 of the solicitation offers contacts to whom general inquiries can be made, including NIDA's contact,  Dr. Karen Skinner).  Learn more about ongoing Federal government programs that address the challenges of, and tap the opportunities afforded by, the big data revolution in this Big Data Fact Sheet.

PROPOSAL DEADLINES; Full proposal deadlines are June 13, 2012 for Mid-scale projects, and July 11, 2012 for Small Projects.

 

-------

 

TO UNSUBSCRIBE: send email to listserv@list.nih.gov, Copy and paste UNSUBSCRIBE NIDA_NEURO_SCIENCE-L   in the message body of the email

- You will receive a confirmation email if successful. If you have problems contact jpollock@mail.nih.gov 301-435-1309